PharmAdva, LLC

New Filing

CIK: 0002067748·Manufacturing·NEW YORK·Filed: Jan 22, 2026

Total Offering

$1,000,000

Amount Sold

$550,000

Investors

2

First Sale

Jan 21, 2026

Offering Details

Type: Equity
Exemptions: Rule 506(b)

Related Persons

Name	Role
Jonathan Sacks	Director
Mark Ambruster	Director
Michael Allen	Director
Pamela Schwitzer	Director
Jim Brush	Director
Michael Berg	Executive Officer, Director
Joel Reiser	Director

Company

1565 JEFFERSON ROAD

ROCHESTER, NY, 14623

844-606-3474

SEC Filing

0002067748-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.